ABIVAX Société Anonyme (AAVXF)
OTCMKTS · Delayed Price · Currency is USD
7.28
0.00 (0.00%)
Jul 15, 2025, 4:00 PM EDT
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 69 employees as of December 31, 2024. The number of employees increased by 8 or 13.11% compared to the previous year.
Employees
69
Change (1Y)
8
Growth (1Y)
13.11%
Revenue / Employee
$165,855
Profits / Employee
-$2,909,594
Market Cap
583.72M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo, Inc. | 3,116 |
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 68 |
Glass House Brands | 374 |
CytoDyn | 9 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
ABIVAX Société Anonyme News
- 4 weeks ago - Abivax Announces Results of its June 6, 2025 Annual General Meeting - GlobeNewsWire
- 6 weeks ago - Abivax reports Q1 results - Seeking Alpha
- 6 weeks ago - Abivax Presents First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis - GlobeNewsWire
- 3 months ago - Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones - GlobeNewsWire
- 3 months ago - Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors - GlobeNewsWire
- 3 months ago - ABIVAX: Undercovered, Late-Stage French Company With Upcoming Catalysts - Seeking Alpha
- 3 months ago - Abivax publishes financial reports with the French and U.S. securities regulatory agencies - GlobeNewsWire